Jefferies Maintains a 'Buy' on Celgene (CELG); Positive Feedback in Myeloma Survey
Tweet Send to a Friend
Jefferies maintains a 'Buy' on Celgene (NASDAQ: CELG) price target of $81.00 (from $80.00).
Analyst, Thomas Wei, said, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Thomas Wei, said, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE